Comparing Aetna (AET) & The Competition
Aetna (NYSE: AET) is one of 14 publicly-traded companies in the “Managed Health Care” industry, but how does it contrast to its competitors? We will compare Aetna to similar businesses based on the strength of its analyst recommendations, risk, valuation, profitability, institutional ownership, dividends and earnings.
Valuation & Earnings
This table compares Aetna and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Aetna||$62.20 billion||$6.06 billion||35.12|
|Aetna Competitors||$52.70 billion||$3.80 billion||18.06|
Aetna has higher revenue and earnings than its competitors. Aetna is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Insider and Institutional Ownership
89.5% of Aetna shares are owned by institutional investors. Comparatively, 90.2% of shares of all “Managed Health Care” companies are owned by institutional investors. 0.9% of Aetna shares are owned by company insiders. Comparatively, 2.4% of shares of all “Managed Health Care” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This table compares Aetna and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Aetna has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, Aetna’s competitors have a beta of 0.76, meaning that their average stock price is 24% less volatile than the S&P 500.
This is a breakdown of recent ratings and price targets for Aetna and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aetna currently has a consensus price target of $163.69, indicating a potential upside of 1.77%. As a group, “Managed Health Care” companies have a potential downside of 0.03%. Given Aetna’s stronger consensus rating and higher probable upside, equities analysts plainly believe Aetna is more favorable than its competitors.
Aetna pays an annual dividend of $2.00 per share and has a dividend yield of 1.2%. Aetna pays out 43.7% of its earnings in the form of a dividend. As a group, “Managed Health Care” companies pay a dividend yield of 0.9% and pay out 20.9% of their earnings in the form of a dividend.
Aetna beats its competitors on 9 of the 15 factors compared.
Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.